Comparison of serum copper levels between coronary artery disease patients and normal individuals: a case-control study
Abstract
Cardiovascular diseases (CVD) are the leading causes of death in technologically developed and developing countries. Copper, an active redox element, is involved in energy production through various mechanisms. Copper and coronary artery disease can be associated directly, through its direct effect on the vascular endothelium, or indirectly through lipoprotein metabolism. Hence an evaluation of copper in the coronary artery disease individual is important.
The aim is to compare the relationship of serum copper levels between coronary artery disease patients and control individuals based on age, sex, hypertension and diabetes mellitus.
Materials and methods: The study design was a case-control study in which proven coronary artery disease patients attending cardiology OPD were selected as cases. Control individuals were mainly selected from the master health check-up. Serum copper levels, plasma glucose, cholesterol, serum triglycerides, and serum HDL & LDL cholesterol were done. Glycated haemoglobin (HbA1C) was also measured. The data were analyzed using IBM SPSS software version 24.
Result: The correlation of serum copper level with other quantitative parameters is determined by calculating Pearson’s correlation coefficient among cases and controls.
Conclusion: The serum copper level is significantly (p=0.001) higher in CAD patients than in age, sex, DM, and HT-matched controls. The serum copper level has a significant (p=0.001) effect on disease, and the adjusted odds ratio is 1.032 (CI 1.011–1.054). In addition, the serum copper level has a significant (0.01) negative correlation with LDL cholesterol and total cholesterol.
Downloads
References
Varbo, A., Benn, M., Smith, G. D., Timpson, N. J., Tybjærg-Hansen, A., Nordestgaard, B. G. (2015). Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Blood Pressure as Mediators From Obesity to Ischemic Heart Disease. Circulation Research, 116 (4), 665–673. doi: https://doi.org/10.1161/circresaha.116.304846
Essien, O. E., Andy, J., Ansa, V., Otu, A. A., Udoh, A. (2014). Coronary Artery Disease and the Profile of Cardiovascular Risk Factors in South South Nigeria: A Clinical and Autopsy Study. Cardiology Research and Practice, 2014, 1–7. doi: https://doi.org/10.1155/2014/804751
Calder, P. C. (2012). The role of marine omega-3 ( n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Molecular Nutrition & Food Research, 56 (7), 1073–1080. doi: https://doi.org/10.1002/mnfr.201100710
Helkin, A., Stein, J. J., Lin, S., Siddiqui, S., Maier, K. G., Gahtan, V. (2016). Dyslipidemia Part 1 – Review of Lipid Metabolism and Vascular Cell Physiology. Vascular and Endovascular Surgery, 50 (2), 107–118. doi: https://doi.org/10.1177/1538574416628654
Ramesh, M. J., Kulkarni, D. G. (2016). Evaluation of Effect of Trace Elements And Antioxidants Levels In Patient With Ischaemic Heart. International Journal of Biotechnology and Biochemistry, 12 (2), 145–151.
World Health Organization. Global Status Report on Non-Communicable Diseases (2014). Geneva: World Health Organization. Available at: https://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf
Charo, I. F., Taub, R. (2011). Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nature Reviews Drug Discovery, 10 (5), 365–376. doi: https://doi.org/10.1038/nrd3444
Wong, N. D. (2014). Epidemiological studies of CHD and the evolution of preventive cardiology. Nature Reviews Cardiology, 11 (5), 276–289. doi: https://doi.org/10.1038/nrcardio.2014.26
Alwan, A. (Ed.) (2016). Global Status Report on Non-Communicable Diseases 2016. WHO.
Styczeń, K., Siwek, M., Sowa-Kućma, M., Dudek, D., Reczyński, W., Szewczyk, B. et al. (2015). The serum magnesium concentration as a potential state marker in patients with unipolar affective disorder. Psychiatria Polska, 49 (6), 1265–1276. doi: https://doi.org/10.12740/pp/onlinefirst/44137
Gerhard, D. M., Wohleb, E. S., Duman, R. S. (2016). Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity. Drug Discovery Today, 21 (3), 454–464. doi: https://doi.org/10.1016/j.drudis.2016.01.016
Lee, J., Joo, E.-J., Lim, H.-J., Park, J.-M., Lee, K. Y., Park, A., Seok, A., Lee, H., & Kang, H.-G. (2015). Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses. Psychiatry Investigation, 12 (2), 249–259. doi: https://doi.org/10.4306/pi.2015.12.2.249
Pytka, K., Dziubina, A., Młyniec, K., Dziedziczak, A., Żmudzka, E., Furgała, A. et al. (2016). The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect. Pharmacological Reports, 68 (2), 443–450. doi: https://doi.org/10.1016/j.pharep.2015.10.006
Bandmann, O., Weiss, K. H., Kaler, S. G. (2015). Wilson’s disease and other neurological copper disorders. The Lancet Neurology, 14, 103–113. doi: https://doi.org/10.1016/s1474-4422(14)70190-5
Mokhberi, V., Bagheri, B., Akbari, N., Tabiban, S., Habibi, V. (2015). Serum level of copper in patients with coronary artery disease. Nigerian Medical Journal, 56 (1), 39–42. doi: https://doi.org/10.4103/0300-1652.149169
Młyniec, K., Gaweł, M., Doboszewska, U., Starowicz, G., Pytka, K., Davies, C. L., Budziszewska, B. (2015). Essential elements in depression and anxiety. Part II. Pharmacological Reports, 67 (2), 187–194. doi: https://doi.org/10.1016/j.pharep.2014.09.009
Grubman, A., White, A. R. (2014). Copper as a key regulator of cell signalling pathways. Expert Reviews in Molecular Medicine, 16. doi: https://doi.org/10.1017/erm.2014.11
A. Al-Dohan, J., S.Haddad, N., Al-Rubaye, H. (2015). The Relation between Trace Elements Levels and Some Cardiovascular Risk Factors in Patients with Obstructive Coronary Artery Disease in Basra. Biology and Medicine, s3. doi: https://doi.org/10.4172/0974-8369.1000s3010
Scheiber, I. F., Mercer, J. F. B., Dringen, R. (2014). Metabolism and functions of copper in brain. Progress in Neurobiology, 116, 33–57. doi: https://doi.org/10.1016/j.pneurobio.2014.01.002
Copyright (c) 2023 Zinnia Shivaji Rajan, Sowndharya Jaganathan, Synthiya Arokiasamy, Suganya Kandhi, Pothanur Mayavan Sasikala
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
